Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Maternal-Fetal Exchange | 2 | 2018 | 455 | 1.100 |
Why?
|
| Child Development | 7 | 2019 | 2223 | 0.860 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2019 | 2026 | 0.780 |
Why?
|
| HIV Infections | 31 | 2020 | 16718 | 0.770 |
Why?
|
| Nervous System | 2 | 2018 | 554 | 0.590 |
Why?
|
| Anti-Retroviral Agents | 7 | 2018 | 1715 | 0.530 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2018 | 1873 | 0.440 |
Why?
|
| Botswana | 7 | 2019 | 1040 | 0.410 |
Why?
|
| Anti-HIV Agents | 6 | 2018 | 4256 | 0.380 |
Why?
|
| Executive Function | 4 | 2017 | 1362 | 0.310 |
Why?
|
| Infectious Disease Transmission, Vertical | 6 | 2017 | 1320 | 0.300 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2019 | 615 | 0.260 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2019 | 2408 | 0.250 |
Why?
|
| Environmental Exposure | 1 | 2018 | 4236 | 0.230 |
Why?
|
| HIV Protease Inhibitors | 2 | 2018 | 430 | 0.220 |
Why?
|
| Cytomegalovirus Infections | 2 | 2020 | 821 | 0.220 |
Why?
|
| Patient Compliance | 5 | 2011 | 2684 | 0.200 |
Why?
|
| Tetanus Toxoid | 1 | 2020 | 193 | 0.170 |
Why?
|
| Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
| Infant | 15 | 2021 | 35129 | 0.160 |
Why?
|
| Benzoxazines | 1 | 2019 | 301 | 0.150 |
Why?
|
| HIV-1 | 4 | 2019 | 6938 | 0.150 |
Why?
|
| Infant Mortality | 2 | 2019 | 754 | 0.140 |
Why?
|
| Infant Formula | 1 | 2018 | 199 | 0.140 |
Why?
|
| Cochlear Implantation | 2 | 2012 | 310 | 0.140 |
Why?
|
| Medication Adherence | 3 | 2013 | 2062 | 0.140 |
Why?
|
| Viremia | 1 | 2019 | 736 | 0.130 |
Why?
|
| Chickenpox Vaccine | 1 | 2015 | 79 | 0.130 |
Why?
|
| Parenting | 1 | 2021 | 679 | 0.130 |
Why?
|
| Pregnancy, Unplanned | 1 | 2016 | 95 | 0.130 |
Why?
|
| Chickenpox | 1 | 2015 | 131 | 0.130 |
Why?
|
| Pregnancy | 9 | 2019 | 29142 | 0.130 |
Why?
|
| Adolescent | 30 | 2018 | 85759 | 0.120 |
Why?
|
| Contraception Behavior | 1 | 2016 | 185 | 0.120 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1348 | 0.110 |
Why?
|
| Adolescent Behavior | 2 | 2012 | 1151 | 0.110 |
Why?
|
| Memory Disorders | 2 | 2017 | 1184 | 0.110 |
Why?
|
| Behavior | 1 | 2016 | 560 | 0.110 |
Why?
|
| Cognition Disorders | 4 | 2012 | 4041 | 0.110 |
Why?
|
| Child | 29 | 2019 | 77679 | 0.100 |
Why?
|
| Viral Load | 5 | 2017 | 3300 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2018 | 25618 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 820 | 0.100 |
Why?
|
| Caregivers | 5 | 2016 | 2094 | 0.090 |
Why?
|
| Prospective Studies | 14 | 2018 | 53280 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2016 | 1147 | 0.090 |
Why?
|
| Female | 37 | 2021 | 380197 | 0.090 |
Why?
|
| Deafness | 2 | 2012 | 461 | 0.090 |
Why?
|
| Neuropsychological Tests | 7 | 2017 | 6991 | 0.090 |
Why?
|
| Young Adult | 10 | 2019 | 56436 | 0.090 |
Why?
|
| Social Responsibility | 2 | 2012 | 389 | 0.090 |
Why?
|
| AIDS Dementia Complex | 1 | 2010 | 153 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 2 | 2016 | 1148 | 0.090 |
Why?
|
| Psychometrics | 1 | 2018 | 3002 | 0.080 |
Why?
|
| Patient Selection | 2 | 2012 | 4216 | 0.080 |
Why?
|
| Child, Preschool | 14 | 2019 | 40992 | 0.080 |
Why?
|
| Male | 33 | 2021 | 350027 | 0.080 |
Why?
|
| Memory | 1 | 2017 | 2174 | 0.080 |
Why?
|
| Cognition | 2 | 2016 | 6765 | 0.070 |
Why?
|
| Child Behavior | 1 | 2012 | 838 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1637 | 0.070 |
Why?
|
| Adolescent Development | 1 | 2009 | 278 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2011 | 807 | 0.070 |
Why?
|
| Cochlear Implants | 1 | 2010 | 339 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2016 | 2576 | 0.070 |
Why?
|
| Humans | 40 | 2021 | 744220 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2018 | 2559 | 0.060 |
Why?
|
| Checklist | 1 | 2012 | 830 | 0.060 |
Why?
|
| Nucleosides | 1 | 2005 | 138 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 791 | 0.060 |
Why?
|
| Nervous System Diseases | 2 | 2014 | 1623 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3176 | 0.060 |
Why?
|
| Virus Replication | 1 | 2011 | 2534 | 0.060 |
Why?
|
| Public Health | 1 | 2016 | 2603 | 0.060 |
Why?
|
| Longitudinal Studies | 6 | 2016 | 13990 | 0.050 |
Why?
|
| Wechsler Scales | 2 | 2012 | 260 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1574 | 0.050 |
Why?
|
| Parents | 2 | 2012 | 3407 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
| Adult | 7 | 2019 | 214035 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 2862 | 0.040 |
Why?
|
| Cross-Sectional Studies | 7 | 2015 | 25043 | 0.040 |
Why?
|
| Cohort Studies | 7 | 2020 | 40559 | 0.040 |
Why?
|
| Alkynes | 1 | 2019 | 306 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2008 | 1859 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 881 | 0.040 |
Why?
|
| Cyclopropanes | 1 | 2019 | 416 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3888 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4455 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 3923 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2020 | 368 | 0.040 |
Why?
|
| Family | 1 | 2008 | 3148 | 0.040 |
Why?
|
| Age Factors | 4 | 2012 | 18367 | 0.040 |
Why?
|
| Prevalence | 4 | 2016 | 15226 | 0.040 |
Why?
|
| Quality of Life | 1 | 2016 | 12805 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2015 | 402 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 3658 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 850 | 0.030 |
Why?
|
| Condoms | 1 | 2016 | 323 | 0.030 |
Why?
|
| Linear Models | 2 | 2017 | 5953 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 2016 | 563 | 0.030 |
Why?
|
| Intention | 1 | 2016 | 341 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2020 | 1904 | 0.030 |
Why?
|
| United States | 6 | 2017 | 69867 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2019 | 906 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2011 | 6601 | 0.030 |
Why?
|
| Intelligence | 2 | 2011 | 920 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2020 | 3203 | 0.020 |
Why?
|
| Perinatal Care | 1 | 2013 | 227 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2012 | 363 | 0.020 |
Why?
|
| Intelligence Tests | 2 | 2008 | 505 | 0.020 |
Why?
|
| E-Selectin | 1 | 2011 | 579 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2016 | 1086 | 0.020 |
Why?
|
| P-Selectin | 1 | 2011 | 600 | 0.020 |
Why?
|
| Language Development | 1 | 2010 | 187 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2017 | 1339 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 617 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2796 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2011 | 894 | 0.020 |
Why?
|
| Africa | 1 | 2010 | 673 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8321 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2013 | 971 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 788 | 0.020 |
Why?
|
| Self Care | 1 | 2012 | 786 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 12244 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2050 | 0.020 |
Why?
|
| Premature Birth | 1 | 2018 | 1721 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19907 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2016 | 2056 | 0.020 |
Why?
|
| Motivation | 1 | 2016 | 1971 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15161 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 2374 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2016 | 2616 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4929 | 0.010 |
Why?
|
| Body Height | 1 | 2009 | 1576 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15538 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10182 | 0.010 |
Why?
|
| Histidine | 1 | 1983 | 313 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6461 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2277 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3201 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2010 | 2902 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2539 | 0.010 |
Why?
|
| Risk Factors | 3 | 2012 | 72280 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6367 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2012 | 2529 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1983 | 255 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3778 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21752 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 4666 | 0.010 |
Why?
|
| Phenylketonurias | 1 | 1979 | 122 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3749 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7784 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 7908 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39045 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2010 | 3444 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13409 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29050 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10396 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1976 | 1525 | 0.010 |
Why?
|
| Leukemia | 1 | 1976 | 1508 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 63119 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 77426 | 0.000 |
Why?
|
| Stanford-Binet Test | 1 | 1979 | 3 | 0.000 |
Why?
|
| Phenylalanine | 1 | 1979 | 365 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1976 | 313 | 0.000 |
Why?
|
| Developmental Disabilities | 1 | 1983 | 1456 | 0.000 |
Why?
|
| Cytarabine | 1 | 1976 | 692 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1976 | 13668 | 0.000 |
Why?
|
| Movement Disorders | 1 | 1976 | 445 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1976 | 2236 | 0.000 |
Why?
|
| Methotrexate | 1 | 1976 | 1720 | 0.000 |
Why?
|
| Folic Acid | 1 | 1976 | 1300 | 0.000 |
Why?
|
| Time Factors | 2 | 1979 | 40063 | 0.000 |
Why?
|
| Phenotype | 1 | 1983 | 16365 | 0.000 |
Why?
|
| Seizures | 1 | 1976 | 2859 | 0.000 |
Why?
|
Concepts
(178)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_